Reaction
Living In Residential Institution reporting signals
As of the last recalculation, Living In Residential Institution appears in 1,858 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is CINACALCET HYDROCHLORIDE (PRR 58.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cinacalcet Hydrochloride | 214 | 58.0 | 58.3 |
| Carbidopa And Levodopa | 171 | 44.4 | 44.5 |
| Clozapine | 366 | 40.4 | 40.5 |
| Levodopa | 24 | 22.5 | 22.6 |
| Amikacin | 24 | 16.0 | 16.0 |
| Darbepoetin Alfa | 59 | 12.6 | 12.6 |
| Pimavanserin Tartrate | 55 | 11.5 | 11.5 |
| Amantadine | 15 | 10.9 | 11.0 |
| Cenobamate | 8 | 10.8 | 10.8 |
| Patiromer | 13 | 10.6 | 10.6 |
| Rotigotine | 12 | 9.3 | 9.4 |
| Dalfampridine | 56 | 9.0 | 9.0 |
| Oxybutynin Chloride | 7 | 9.0 | 9.0 |
| Rivastigmine | 14 | 8.4 | 8.4 |
| Donepezil Hydrochloride | 27 | 8.3 | 8.4 |
| Rasagiline Mesylate | 8 | 8.1 | 8.1 |
| Ropinirole | 11 | 8.1 | 8.1 |
| Paliperidone Palmitate | 21 | 7.4 | 7.4 |
| Erythropoietin | 12 | 6.6 | 6.6 |
| Carboxymethylcellulose Sodium | 5 | 6.0 | 6.0 |
| Insulin Degludec | 12 | 5.8 | 5.8 |
| Denosumab | 89 | 5.1 | 5.1 |
| Mirabegron | 17 | 5.0 | 5.0 |
| Bosentan | 21 | 4.7 | 4.7 |
| Esketamine Hydrochloride | 6 | 3.8 | 3.8 |
| Teriparatide | 37 | 3.7 | 3.7 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 3 | 3.2 | 3.2 |
| Droxidopa | 6 | 3.1 | 3.1 |